🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Andres Cardenas, MD, a great editor, friend, and mentor Interesting side note: two of the three AASLD journals have EIC who trained at BIDMC_GI

BREAKING: rifaximin and simvastatin did not help people with decompensated cirrhosis Congratulations to ELISA POSE And congrats to JAMA for getting this paper

Data on the bugs that cause SBP is so old UNTIL NOW! Thank you Nadim Mahmud Varies with Child Class. Staph is climbing the charts! pdfs.journals.lww.com/hepcomm/2025/0…

You're invited to join global experts in multidisciplinary discussions to advance the science and care of alcohol-associated liver disease (ALD). Sign up to attend the ALD-ALLY Conference and deep dive into the latest developments concerning ALD at loom.ly/Abhcelg.

Lower child opportunity index is associated with increased healthcare utilization following pediatric liver transplantation @PennGIHep Marina Serper, MD, MS journals.lww.com/lt/abstract/99…

Thank you CU Transplant Center for this amazing opportunity. Enjoyed presenting my research, making new friends, meeting awesome faculty, and hearing about many controversial topics in transplant! Wouldn't be possible without Nadim Mahmud Marina Serper, MD, MS @PennGIHep

How reversible is hepatic encephalopathy after all In some cases, the damage persists Important paper: journals.lww.com/hepcomm/fullte… Hey, Marina Serper, MD, MS, maybe we should work on preventing HE?

Very important work from Lauren Nephew MD, MSCE on barriers faced by marginalized individuals for curative HCC Tx. Marina Serper, MD, MS National Cancer Institute Elliot Tapper @fahisakanwal

Thought provoking debate: Are you pro-AI vs pro-MELD for organ allocation? journals.lww.com/lt/abstract/99… journals.lww.com/lt/abstract/99… #Livertwitter

I just learned that our letter to the editor is about one of TWO NEJM articles in 2025 that says naltrexone is contraindicated in cirrhosis There is no evidence for this claim We all need to be the change and make progress together.

1/🚨Check out our new study in Journal of Hepatology❗️ Using natural language processing to identify >350,000 patients with #steatosis, we demonstrated that cause-specific mortality differs between #MASLD, #MetALD, and #ALD #LiverTwitter #LiverX @PennGiHep pubmed.ncbi.nlm.nih.gov/40419118/

Marina Serper, MD, MS

1/ Do clinical outcomes differ across steatotic liver disease subtypes? In JAMA Internal Medicine, we report the incidence of adverse liver outcomes, cardiovascular events, and all-cause mortality across MASLD, MetALD, and ALD Rebecca Hubbard David Kaplan @SerperM ⬇️

Don’t miss kym watt, as she breaks down key findings from the #HEPATOLOGY article: “Determining a Safe Washout Period for Immune Checkpoint Inhibitors Prior to Liver Transplantation.” #LiverX youtube.com/watch?v=-9D0Bm…

Incredible innovations will bring more organ transplants to more people and those organs will be able to travel further and function better. Congratulations to Drs Shaver, Bacchetta, Griesemer and Zuckermann. TTS Vanderbilt Health thelancet.com/journals/lance…

Advances in precision immunosuppression will protect transplant recipients from immunosuppression’s toxicities. When the organ does suffer injury, new deep phenotyping tools will tell us why. Congratulations to Alex Loupy, Marta Sablik and Kiran Khush. thelancet.com/journals/lance…

The field of transplant should commit to making this amazing therapy available to all who need it. Congratulations to Drs Jauré, Jha, McElroy, Muller, Oniscu, Serper, Purnell and Scholes-Robertson. ESOTtransplant American Society of Transplantation (AST) thelancet.com/journals/lance…

Check out new research by LDI Fellow Marina Serper (@serperM) on outcomes across steatotic liver disease subtypes. ⤵️